FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1566361325> ?p ?o ?g. }

• W1566361325 endingPage "409" @default.
• W1566361325 startingPage "403" @default.
• W1566361325 abstract "Etoposide (VP16) is a drug used not only for the treatment of lymphoma but also for the collection of peripheral blood stem cells (PBSCs). We analysed the efficacy and adverse effects of collecting PBSCs and the relation between the infused cell dose and the clinical outcome in lymphoid malignancies.Investigating 30 patients with non-Hodgkin's lymphoma, one patient with Hodgkin's lymphoma, and five patients with multiple myeloma, we compared the effects of several doses of etoposide with those of CHOP or CHOP-like treatments or salvage treatments. We also analysed the relation between the amount of CD34(+) cells collected (above or below 5.0 × 10(6) /kg/day) and prognosis of these patients.We found the collected cell count to be highest in patients treated with 500 mg/m(2) of VP16 and lowest in those not treated with VP16 (P = 0.0073). A CD34(+) cell count above 100/μL on the collection day indicates that the target amount of CD34(+) cells (4.0 × 10(6) /kg) can be readily obtained and was reached most rapidly by the patients who had received 500 mg/m(2) of VP16 (P = 0.01). The longer duration of neutropenia in those patients (P = 0.000006) resulted in longer antibiotic treatment (P = 0.0052). Both progression-free survival (PFS) and overall survival (OS) were better for the patients who yielded more than 5.0 × 10(6) CD34(+) cells/kg/day (P = 0.087 for PFS and P < 0.033 for OS).We show here that 3 days of VP16 at 500 mg/m(2) was useful for the collection of PBSCs and that patients who yielded more than 5.0 × 10(6) CD34(+) cells/kg/day survived longer than those who yielded less." @default.
• W1566361325 created "2016-06-24" @default.
• W1566361325 creator A5017282699 @default.
• W1566361325 creator A5020985742 @default.
• W1566361325 creator A5025953795 @default.
• W1566361325 creator A5026016803 @default.
• W1566361325 creator A5034892457 @default.
• W1566361325 creator A5043888124 @default.
• W1566361325 creator A5054665868 @default.
• W1566361325 creator A5060043861 @default.
• W1566361325 creator A5085155039 @default.
• W1566361325 creator A5085582685 @default.
• W1566361325 date "2012-02-29" @default.
• W1566361325 modified "2023-09-23" @default.
• W1566361325 title "Retrospective analysis of an efficient peripheral blood stem cell collection and the relation between infused cell dose and clinical outcome in patients with malignant lymphoma and multiple myeloma" @default.
• W1566361325 cites W1881943990 @default.
• W1566361325 cites W1965802676 @default.
• W1566361325 cites W1974509065 @default.
• W1566361325 cites W1976933565 @default.
• W1566361325 cites W1980014094 @default.
• W1566361325 cites W1988068150 @default.
• W1566361325 cites W1996945486 @default.
• W1566361325 cites W1997353354 @default.
• W1566361325 cites W2019484447 @default.
• W1566361325 cites W2023072101 @default.
• W1566361325 cites W2023512317 @default.
• W1566361325 cites W2032908755 @default.
• W1566361325 cites W2047915122 @default.
• W1566361325 cites W2051497664 @default.
• W1566361325 cites W2066068982 @default.
• W1566361325 cites W2069060559 @default.
• W1566361325 cites W2075884310 @default.
• W1566361325 cites W2121763019 @default.
• W1566361325 cites W2125887123 @default.
• W1566361325 cites W2157754223 @default.
• W1566361325 cites W2158424965 @default.
• W1566361325 cites W2171615521 @default.
• W1566361325 cites W2226646139 @default.
• W1566361325 cites W92846538 @default.
• W1566361325 doi "https://doi.org/10.1111/j.1751-553x.2012.01410.x" @default.
• W1566361325 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22376221" @default.
• W1566361325 hasPublicationYear "2012" @default.
• W1566361325 type Work @default.
• W1566361325 sameAs 1566361325 @default.
• W1566361325 citedByCount "0" @default.
• W1566361325 crossrefType "journal-article" @default.
• W1566361325 hasAuthorship W1566361325A5017282699 @default.
• W1566361325 hasAuthorship W1566361325A5020985742 @default.
• W1566361325 hasAuthorship W1566361325A5025953795 @default.
• W1566361325 hasAuthorship W1566361325A5026016803 @default.
• W1566361325 hasAuthorship W1566361325A5034892457 @default.
• W1566361325 hasAuthorship W1566361325A5043888124 @default.
• W1566361325 hasAuthorship W1566361325A5054665868 @default.
• W1566361325 hasAuthorship W1566361325A5060043861 @default.
• W1566361325 hasAuthorship W1566361325A5085155039 @default.
• W1566361325 hasAuthorship W1566361325A5085582685 @default.
• W1566361325 hasConcept C10205521 @default.
• W1566361325 hasConcept C126322002 @default.
• W1566361325 hasConcept C2776364478 @default.
• W1566361325 hasConcept C2776694085 @default.
• W1566361325 hasConcept C2776755627 @default.
• W1566361325 hasConcept C2777063308 @default.
• W1566361325 hasConcept C2778119113 @default.
• W1566361325 hasConcept C2778476748 @default.
• W1566361325 hasConcept C2779338263 @default.
• W1566361325 hasConcept C2779429289 @default.
• W1566361325 hasConcept C2779725641 @default.
• W1566361325 hasConcept C28328180 @default.
• W1566361325 hasConcept C54355233 @default.
• W1566361325 hasConcept C71924100 @default.
• W1566361325 hasConcept C86803240 @default.
• W1566361325 hasConcept C90924648 @default.
• W1566361325 hasConceptScore W1566361325C10205521 @default.
• W1566361325 hasConceptScore W1566361325C126322002 @default.
• W1566361325 hasConceptScore W1566361325C2776364478 @default.
• W1566361325 hasConceptScore W1566361325C2776694085 @default.
• W1566361325 hasConceptScore W1566361325C2776755627 @default.
• W1566361325 hasConceptScore W1566361325C2777063308 @default.
• W1566361325 hasConceptScore W1566361325C2778119113 @default.
• W1566361325 hasConceptScore W1566361325C2778476748 @default.
• W1566361325 hasConceptScore W1566361325C2779338263 @default.
• W1566361325 hasConceptScore W1566361325C2779429289 @default.
• W1566361325 hasConceptScore W1566361325C2779725641 @default.
• W1566361325 hasConceptScore W1566361325C28328180 @default.
• W1566361325 hasConceptScore W1566361325C54355233 @default.
• W1566361325 hasConceptScore W1566361325C71924100 @default.
• W1566361325 hasConceptScore W1566361325C86803240 @default.
• W1566361325 hasConceptScore W1566361325C90924648 @default.
• W1566361325 hasIssue "4" @default.
• W1566361325 hasLocation W15663613251 @default.
• W1566361325 hasLocation W15663613252 @default.
• W1566361325 hasOpenAccess W1566361325 @default.
• W1566361325 hasPrimaryLocation W15663613251 @default.
• W1566361325 hasRelatedWork W1566361325 @default.
• W1566361325 hasRelatedWork W160156331 @default.
• W1566361325 hasRelatedWork W1979383340 @default.
• W1566361325 hasRelatedWork W2158035792 @default.
• W1566361325 hasRelatedWork W2178567417 @default.

• next